CompletedPhase 2NCT05104099
Evaluation of New Diagnostic Tool Using Fluorescence to Detect High-grade Vulvar Intraepithelial Neoplasia
Studying Vulvar intraepithelial neoplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Institut de Cancérologie de Lorraine
- Principal Investigator
- Lorraine HEJL, MDInstitut de Cancérologie de Lorraine
- Intervention
- Metvixia Topical Cream(drug)
- Enrollment
- 17 target
- Eligibility
- 18 years · FEMALE
- Timeline
- 2021 – 2025
Study locations (1)
- Institut de Cancerologie de Lorraine, Vandœuvre-lès-Nancy, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05104099 on ClinicalTrials.gov